|
1
|
Villanueva A, Hernandez-Gea V and Llovet
JM: Medical therapies for hepatocellular carcinoma: a critical view
of the evidence. Nat Rev Gastroenterol Hepatol. 10:34–42. 2013.
View Article : Google Scholar
|
|
2
|
Qing P, Han L, Bin L, Yan L and Ping WX:
USP7 regulates the stability and function of HLTF through
deubiquitination. J Cell Biochem. 112:3856–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nicholson B and Suresh Kumar KG: The
multifaceted roles of USP7: new therapeutic opportunities. Cell
Biochem Biophys. 60:61–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JT and Gu W: The multiple levels of
regulation by p53 ubiquitination. Cell Death Differ. 17:86–92.
2010. View Article : Google Scholar
|
|
5
|
Colland F: The therapeutic potential of
deubiquitinating enzyme inhibitors. Biochem Soc Trans. 38:137–143.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee MH and Lozano G: Regulation of the
p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer
Biol. 16:225–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meulmeester E, Maurice MM, Boutell C, et
al: Loss of HAUSP-mediated deubiquitination contributes to DNA
damage-induced destabilization of Hdmx and Hdm2. Mol Cell.
18:565–576. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Xing R, Zhang X, et al: miR-375
targets the p53 gene to regulate cellular response to ionizing
radiation and etoposide in gastric cancer cells. DNA Repair.
12:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagano H, Tomimaru Y, Eguchi H, et al:
MicroRNA-29a induces resistance to gemcitabine through the
Wnt/beta-catenin signaling pathway in pancreatic cancer cells. Int
J Oncol. 43:1066–1072. 2013.PubMed/NCBI
|
|
12
|
Zhang S, Shan C, Kong G, Du Y, Ye L and
Zhang X: MicroRNA-520e suppresses growth of hepatoma cells by
targeting the NF-kappaB-inducing kinase (NIK). Oncogene.
31:3607–3620. 2012. View Article : Google Scholar
|
|
13
|
Giordano S and Columbano A: MicroRNAs: new
tools for diagnosis, prognosis and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar
|
|
14
|
Wong CM, Kai AK, Tsang FH and Ng IO:
Regulation of hepatocar-cinogenesis by microRNAs. Front Biosci
(Elite edi). 5:49–60. 2013.
|
|
15
|
Hou J, Lin L, Zhou W, et al:
Identification of miRNomes in human liver and hepatocellular
carcinoma reveals miR-199a/b-3p as therapeutic target for
hepatocellular carcinoma. Cancer Cell. 19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su N, Qiu H, Chen Y, Yang T, Yan Q and Wan
X: miR-205 promotes tumor proliferation and invasion through
targeting ESRRG in endometrial carcinoma. Oncology Reports.
29:2297–2302. 2013.PubMed/NCBI
|
|
17
|
Cai J, Fang L, Huang Y, et al: miR-205
targets PTEN and PHLPP2 to augment AKT signaling and drive
malignant phenotypes in non-small cell lung cancer. Cancer Res.
73:5402–5415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang N, Li Q, Feng NH, et al: miR-205 is
frequently down-regulated in prostate cancer and acts as a tumor
suppressor by inhibiting tumor growth. Asian J Androl. 15:735–741.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Huo S, Shan Y, et al: STAT3
repressed USP7 expression is crucial for colon cancer development.
FEBS Lett. 586:3013–3017. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Loosdregt J, Fleskens V, Fu J, et al:
Stabilization of the transcription factor Foxp3 by the
deubiquitinase USP7 increases Treg-cell-suppressive capacity.
Immunity. 39:259–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
